366.00
+2.3(+0.63%)
Currency In INR
| Previous Close | 363.7 |
| Open | 364 |
| Day High | 367.85 |
| Day Low | 362.5 |
| 52-Week High | 406 |
| 52-Week Low | 291 |
| Volume | 675,561 |
| Average Volume | 4.81M |
| Market Cap | 489.33B |
| PE | 114.38 |
| EPS | 3.2 |
| Moving Average 50 Days | 371.26 |
| Moving Average 200 Days | 352.51 |
| Change | 2.3 |
If you invested ₹1000 in Biocon Limited (BIOCON.NS) 10 years ago, it would be worth ₹5,185.6 as of September 08, 2025 at a share price of ₹366. Whereas If you bought ₹1000 worth of Biocon Limited (BIOCON.NS) shares 5 years ago, it would be worth ₹888 as of September 08, 2025 at a share price of ₹366.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™, the First and Only Interchangeable Rapid-Acting Insulin Aspart in the United States
GlobeNewswire Inc.
Jul 15, 2025 7:25 PM GMT
BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), today annou